Pathophysiology of Atrial Fibrillation
Comprehensive analysis of electrical remodeling, thromboembolic risk, and contemporary rate vs. rhythm control strategies based on the 2024 ESC Guidelines.
Evidence-based, peer-reviewed coverage of human physiology, pathology, diagnostics, therapeutics, and emerging medical research. Updated continuously by clinical experts and researchers worldwide.
Comprehensive analysis of electrical remodeling, thromboembolic risk, and contemporary rate vs. rhythm control strategies based on the 2024 ESC Guidelines.
Deep dive into checkpoint inhibitors, CAR-T cell adaptations, and biomarker-driven patient selection for precision oncology applications.
Current understanding of amyloid-beta, tau tangles, neuroinflammation, and emerging disease-modifying therapies in late-stage clinical trials.
Updated coverage on dosing protocols, metabolic pathways, and long-term cardiovascular safety data.
Revised transmission guidelines, vaccination strategies, and diagnostic algorithms for healthcare settings.
Longitudinal 24-month follow-up data showing sustained hemoglobin elevation and reduced vaso-occlusive crises.